AT1001 for the Treatment of Long COVID

Clinical trial NCT05747534 · COMPLETED

Trial details

NCT number: NCT05747534
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Long COVID Long COVID-19 Post Acute COVID-19 Syndrome Post Acute Sequelae of COVID-19

Start date: 2023-05-31
Primary completion: 2026-06-18
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.